Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic drug monitoring of atazanavir in HIV-infected patients with end-stage liver disease evaluated for orthotopic liver transplantation
2005-004936-34Phase 4Completed
- Sponsor
- AOU Policlinico di Modena
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of atazanavir in human immunodeficiency virus infection (HIV) and hepatic disease, sponsored by AOU Policlinico di Modena. Primary endpoints: Optimal therapeutic range of atazanavir and Dosing nomogram based on Child-Pugh class. Started Sep 2007; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)hepatic disease
Beyond the preview
Go deeper on 2005-004936-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004936-34.